THG Plc (THGHY) Q2 2026 Earnings Call Transcript

THG reported a strong H1 2026, citing revenue growth, a significant increase in profitability and a materially improved free-cash-flow position. The company said its 2025 Ingenuity demerger has shifted it to a capital-light model focused on Nutrition and Beauty, while a roughly 25% reduction in group headcount over the past 18 months has supported cost efficiency. THG also highlighted the prior £103 million sale of Claremont Ingredients as evidence of potential value realization from non-core assets.

Analysis

The investable issue is whether THG has crossed from a restructuring narrative into a self-funding consumer platform. If the reported cash-flow improvement is supported by lower working-capital usage rather than inventory liquidation, the equity can rerate: a sustainable reduction in cash burn lowers both refinancing risk and the conglomerate/governance discount that has constrained valuation. The key underwriting variables for the next 1-3 months are Nutrition repeat-order growth, Beauty gross-margin progression, marketing efficiency, and whether central-cost savings remain intact without impairing customer acquisition.

The near-term risk/reward is asymmetric only if management converts optimistic language into hard guidance upgrades or delivers another period of positive free cash flow. A 25% workforce reduction creates operating leverage, but also raises execution risk in fulfillment, digital acquisition and brand support; any deterioration in revenue growth alongside margin expansion would indicate cost-cutting is masking weaker demand. Further disposals could crystallize asset value and reduce leverage over 6-18 months, but they also narrow the asset base and may signal that internal cash generation remains insufficient.

Consensus may underappreciate the balance-sheet option value from a genuinely capital-light model, while underpricing the possibility that cash conversion is temporary. The appropriate catalyst is not headline EBITDA: it is recurring FCF after leases, restructuring cash costs, interest and normalized inventory investment. Without those disclosures, this remains a watch-list rerating rather than a high-conviction long.

Key Decisions for Investors

• Maintain or initiate only a small tactical long in THG after the full H1 filing confirms positive underlying free cash flow and no deterioration in Nutrition/Beauty revenue growth; target a 1-3 month rerating on upgraded FY guidance, with risk limited by exiting on a return to material cash burn or a guidance cut.
• Use any sharp post-call rally as an opportunity to wait for verification rather than chase: require evidence that inventory days, receivables and payables have not been used to manufacture the cash-flow improvement before increasing exposure.
• Monitor THG's net-debt, lease-liability and interest-cost trajectory at the next results. A disposal that materially reduces financing burden is a 6-18 month bullish catalyst; a sale executed at a distressed valuation or followed by renewed restructuring charges would falsify the sum-of-the-parts thesis.
• No trade in PEEL is implied by this event; its role as call participant does not create a discernible earnings sensitivity.